Clinical Trial Update: Rifaximin in Patients With Diabetic Gastroparesis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for rifaximin in diabetic gastroparesis, sponsored by Mayo Clinic, with the study status terminated; Crohn's disease is also liste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Diabetic Gastroparesis

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Mayo Clinic | Conditions: Crohn Disease, Diabetic Gastroparesis | Phase 2 | Status: TERMINATED